Wordt geladen...
Enoxaparin dose reduction for thrombocytopenia in patients with cancer: a quality assessment study
The development of thrombocytopenia in the setting of therapeutic anticoagulation for venous thromboembolic disease (VTE) is common in cancer patients, but guidelines for management are based on limited past data and have not been validated. In 2011, Memorial Sloan Kettering Cancer Center (MSKCC) im...
Bewaard in:
| Gepubliceerd in: | J Thromb Thrombolysis |
|---|---|
| Hoofdauteurs: | , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Springer US
2017
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5375964/ https://ncbi.nlm.nih.gov/pubmed/28205078 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11239-017-1478-0 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|